RT Journal Article
SR Electronic
T1 Behavioral dynamics of COVID-19: estimating under-reporting, multiple waves, and adherence fatigue across 91 nations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.24.20139451
DO 10.1101/2020.06.24.20139451
A1 Rahmandad, Hazhir
A1 Lim, Tse Yang
A1 Sterman, John
YR 2020
UL http://medrxiv.org/content/early/2020/11/26/2020.06.24.20139451.abstract
AB Effective responses to the COVID-19 pandemic require reliable estimates of actual cases and deaths, and models that incorporate behavioral factors including differential priorities for allocating limited testing capacity, heterogeneous risk perceptions and resulting contact reductions, improved treatment, and adherence fatigue. We develop a behavioral dynamic model integrating these factors with asymptomatic transmission, disease acuity, and hospital capacity. Using a hierarchical Bayesian framework we estimate the model parameters with a panel dataset spanning all 91 nations with reliable testing data. Cumulative cases and deaths through 30 October 2020 are estimated to be 8.5 and 1.4 times greater than official reports, yielding an overall infection fatality rate (IFR) of 0.48%, with wide variation across nations and significant decline in IFR over time. Adherence fatigue is estimated to have increased cumulative cases by 61% through October 2020. Scenarios through March 2021 show modest policy interventions and behavior change could reduce cumulative cases ≈18%. The model endogenously generates the multiple waves of infection and mortality observed in many nations as behavioral responses to perceived risk cause the reproduction number to fluctuate around 1, but with death rates that vary by two orders of magnitude depending on responsiveness to perceived risks.One Sentence Summary COVID-19 under-reporting is large, varies widely across nations, and strongly conditions projected outbreak dynamics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was used to conduct this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, codes, and simulation models are publicly available. https://github.com/tseyanglim/CovidGlobal